Thompson Davis & Co., Inc. Bristol Myers Squibb CO Transaction History

Thompson Davis & Co., Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $43,976 - $51,266	-820 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $55 - $62	1 Added 0.12%	820 $51,000
Q1 2018 May 02, 2018	BUY	$59.92 - $68.98 $7,549 - $8,691	126 Added 18.18%	819 $52,000
Q4 2017 Feb 05, 2018	SELL	$59.94 - $65.35 $9,230 - $10,063	-154 Reduced 18.18%	693 $42,000
Q3 2017 Oct 30, 2017	BUY	$55.23 - $63.74 $15,464 - $17,847	280 Added 49.38%	847 $54,000
Q2 2017 Aug 10, 2017	BUY	N/A	567	567 $32,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.